All In Biotech

Drug Trial Radar · NCT06203210

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)

Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 540 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

540

Planned (sponsor's estimate)

Start

May 21, 2024

Primary completion

Jan 30, 2028

Study completion Dec 1, 2029

Sponsor

Lead sponsor
Daiichi SankyoDaiichi Sankyo (DSNKY)
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Jan 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung cancer (SCLC).

Conditions

  • Small Cell Lung Cancer

Interventions

  • Ifinatamab deruxtecanDrug

    12 mg/kg intravenous dose on Day 1 of each 21-day cycle

  • TopotecanDrug

    Topotecan will be administered per local standard-of-care (SoC)

  • AmrubicinDrug

    Amrubicin will be administered per local SoC

  • LurbinectedinDrug

    Lurbinectedin will be administered per local SoC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: From the date of randomization to the date of death due to any cause, up to approximately 3.7 years

Locations

229 sites in 23 countries. Site status is shown where the registry gives one.

  • Highlands Oncology Group

    Springdale, Arkansas · Recruiting

  • Clinical Research Providence Medical Foundation

    Fullerton, California · Recruiting

  • UCLA Hematology-Oncology

    Los Angeles, California · Recruiting

  • UCSF Mission Bay Mission Hall

    San Francisco, California · Recruiting

  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center

    Miami, Florida · Recruiting

  • AdventHealth Orlando, Cancer Institute

    Orlando, Florida · Recruiting

  • H. Lee Moffitt Cancer Center and Research Institute, Inc

    Tampa, Florida · Not yet recruiting

  • Rush MD Anderson Cancer Center

    Chicago, Illinois · Recruiting

  • Baptist Health Lexington

    Lexington, Kentucky · Recruiting

  • University of Maryland Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland · Recruiting

  • John Hopkins School of Medicine

    Baltimore, Maryland · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Henry Ford Health System

    Detroit, Michigan · Not yet recruiting

  • Mercy Clinic Oncology and Hematology Sindelar Cancer Center

    St Louis, Missouri · Recruiting

  • University of Nebraska Medical Center

    Omaha, Nebraska · Recruiting

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Recruiting

  • Astera Cancer Care

    East Brunswick, New Jersey · Recruiting

  • Hackensack Meridian Health Jsumc

    Neptune City, New Jersey · Recruiting

  • Clinical Research Alliance, Inc

    Lake Success, New York · Recruiting

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island

    New York, New York · Recruiting

  • New York University Cancer Center - Laura and Isaac

    New York, New York · Recruiting

  • Montefiore Medical Center Prime

    The Bronx, New York · Not yet recruiting

  • Cleveland Clinic Mercy Hospital

    Canton, Ohio · Recruiting

  • Oncology/Hematology Care Clinical Trials, Llc

    Cincinnati, Ohio · Recruiting

  • Providence Portland Medical Center

    Portland, Oregon · Not yet recruiting

  • THE WEST CLINIC, PLLC dba West Cancer Center

    Germantown, Tennessee · Recruiting

  • Houston Methodist Cancer Center

    Houston, Texas · Recruiting

  • University of Texas Md Anderson Cancer Center

    Houston, Texas · Recruiting

  • Texas Oncology, P.A. - Tyler

    Tyler, Texas · Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Not yet recruiting

  • Ballarat Base Hospital

    Ballarat, Australia · Recruiting

  • Flinders Medical Centre (Fmc)

    Bedford Park, Australia · Recruiting

  • Chris O Brien Lifehouse

    Camperdown, Australia · Recruiting

  • Sunshine Hospital

    St Albans, Australia · Recruiting

  • St John of God Subiaco Hospital

    Subiaco, Australia · Recruiting

  • Townsville Cancer Centre

    Townsville, Australia · Recruiting

  • Princess Alexandra Hospital

    Woolloongabba, Australia · Recruiting

  • Landeskrankenhaus Feldkirch

    Feldkirch, Austria · Recruiting

  • Landesklinikum Krems

    Krems, Austria · Recruiting

  • Kepler University Hospital

    Linz, Austria · Recruiting

Showing 40 of 229 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.